The company's founder is Dr. Adrian Harel, an experienced neurobiologist with an impressive track record in leadership of early-stage drug discovery companies and business management. His collaboration with renowned experts in medicinal chemistry promises to generate a successful pipeline of innovative therapeutic molecules and diagnostic biomarkers.
Medicortex's CEO, Dr. Adrian Harel, has a PhD in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University. Dr. Harel has many years of experience in the pharmaceutical and biotech industry. Dr. Harel has extensive Drug R&D know-how and GMP production and manufacturing knowledge. He combines a broad scientific education with extensive industry experience.
Medical Director Mårten Kvist has an MD from the University of Helsinki, Finland, and MD/PhD at the University of Turku, Finland. He is an Associate Professor (Docent) in General Practice at the University of Turku and in public Health at the University of Lapland.
Head of R&D Lasse Välimaa has a PhD degree in Molecular Biotechnology and Diagnostics at the University of Turku, Finland. His background is in the R&D of bioanalytical methods and medical diagnostics.
Mr. Tomas Ward, Vice President Sales and Marketing, has experience in managerial positions of private and public medical companies. Experience in successful market launch and IPO in the past. Has successfully transformed a company from a technology driven to a market driven business, achieving a forerunner position internationally, starting from a position with three employees without developed technology and no visibility in the market.
Product Manager, Dr. Begum Utz has a PhD in biological sciences from Vanderbilt University in Nashville, TN, USA. She has key experience in life sciences R&D project management and data analysis. Dr. Utz is responsible for technical planning and development of the diagnostic kit, integration of the chemistry into the assembly and transfer of the prototype from development to the production.
Clinical Research Coordinator Oskar Haavisto has a BSc in biochemistry from the University of Turku. He´s planning to graduate as a Master of Molecular Biotechnology and Diagnostics by 2020.
Our CFO is KLT-accountant Marjukka Iitti. Also a partner and member of the board in Tili-Vinkki Oy.
Professor Heikki Rauvala - Chairman of the SAB, a research director at the Neuroscience Center of University of Helsinki, Finland. Dr. Rauvala has published 213 frequently cited publications relating to his primary research interests; development, plasticity and regeneration of the central nervous system; injuries of the central nervous system; behavioral disorders.
Dr. Antti Kaipia - Chief, Department of Urology, Tampere University Hospital, Finland. Dr. Kaipia has a vast experience in the surgery and in clinical practice of a large central hospital.
Dr. Lauri Kangas - Senior Adviser at a pharmaceutical company, and Chief Scientific Officer, Finland.
Associate professor Timo Kurki - Neuroradiologist and Chief of Medical Imaging at Terveystalo Oy, Finland.
Professor Risto O. Roine - Professor and Chairman, Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Finland. National coordinator for an EU Biomed project with a 2.2-million-euro budget. Dr. Roine has been a Principle Investigator in 15 studies relating to secondary neurological damage and its treatment.
Dr. Markku Tuominen - Chief Physician and CEO of Medisport Oy, Finland. Dr. Tuominen is an experienced physician and key opinion leader in sports injuries. He is a member of the Medical Committee of the International Ice Hockey Federation (IIHF) and he is serving as a physician in the Finnish Ice Hockey Federation.
Chariman of the Board - Dr. Adrian Harel
Member Associate Professor Mårten Kvist, MD, PhD, Medical Director
Member Tom Palenius, Director, Services for Startup Companies at Turku Science Park Oy.